Javascript must be enabled to continue!
Vancomycin resistant enterococci gut Colonization and its associated factors among HIV infected patients on anti-Retro viral therapy in Ethiopia
View through CrossRef
Abstract
BackgroundThe emergence of vancomycin resistant Enterococci (VRE) has alarmed the global infectious diseases community due to its tendency for colonization of the gastrointestinal tract. Human Immunodeficiency Virus (HIV) patients are colonized by vancomycin resistant Enterococci than other groups. The aim of this study was to determine the prevalence of vancomycin resistant Enterococci gut colonization and its associated factors among HIV infected patients on Anti-Retroviral Therapy (ART).MethodsInstitution based cross sectional study was conducted among HIV infected patients on ART at from June 1 to August 30, 2020. Socio-demographic and clinical data were collected by pre-tested structured questionnaire. Stool sample was collected and processed by standard microbiological techniques. Kirby Bauer Disc diffusion method was used to perform antimicrobial susceptibility testing. Data were entered by Epi data version 4.6.0.2 and analyzed by SPSS version 25. P-value <0.05 was considered as significant.ResultsAmong a total of 200 study participants, colonization of Enterococci spp was isolated on 123 (61.50%) respondents. Among these isolates, the prevalence of vancomycin resistant Enterococci colonization was 11.4% [95% CI: (6.0-17.0)]. Enterococci isolates tested against commonly prescribed antibiotics showed highest rate of resistance to ampicillin (69.9%). Multidrug resistances were observed in 49.59% of Enterococci isolates. Study participants who had prior antibiotic exposure for more than two weeks [AOR=7.35; 95% CI: (1.2144.64)] and hospitalization in the last six months [AOR=5.68; 95% CI: (1.09 29.74)] were significantly associated with vancomycin resistant Enterococci gut colonization.ConclusionHigh prevalence of vancomycin resistant Enterococci gut colonization was found. Previous exposure to antibiotics for more than two weeks and previous hospitalization for more than six months were significant factors for vancomycin resistant Enterococci colonization. The isolated Enterococci had variable degrees of resistance to commonly prescribed antibiotics. Therefore, periodic surveillance on antimicrobial resistance pattern, adhering to rational use of antibiotics and implementing infection prevention protocols may reduce colonization by VRE.
Title: Vancomycin resistant enterococci gut Colonization and its associated factors among HIV infected patients on anti-Retro viral therapy in Ethiopia
Description:
Abstract
BackgroundThe emergence of vancomycin resistant Enterococci (VRE) has alarmed the global infectious diseases community due to its tendency for colonization of the gastrointestinal tract.
Human Immunodeficiency Virus (HIV) patients are colonized by vancomycin resistant Enterococci than other groups.
The aim of this study was to determine the prevalence of vancomycin resistant Enterococci gut colonization and its associated factors among HIV infected patients on Anti-Retroviral Therapy (ART).
MethodsInstitution based cross sectional study was conducted among HIV infected patients on ART at from June 1 to August 30, 2020.
Socio-demographic and clinical data were collected by pre-tested structured questionnaire.
Stool sample was collected and processed by standard microbiological techniques.
Kirby Bauer Disc diffusion method was used to perform antimicrobial susceptibility testing.
Data were entered by Epi data version 4.
6.
2 and analyzed by SPSS version 25.
P-value <0.
05 was considered as significant.
ResultsAmong a total of 200 study participants, colonization of Enterococci spp was isolated on 123 (61.
50%) respondents.
Among these isolates, the prevalence of vancomycin resistant Enterococci colonization was 11.
4% [95% CI: (6.
0-17.
0)].
Enterococci isolates tested against commonly prescribed antibiotics showed highest rate of resistance to ampicillin (69.
9%).
Multidrug resistances were observed in 49.
59% of Enterococci isolates.
Study participants who had prior antibiotic exposure for more than two weeks [AOR=7.
35; 95% CI: (1.
2144.
64)] and hospitalization in the last six months [AOR=5.
68; 95% CI: (1.
09 29.
74)] were significantly associated with vancomycin resistant Enterococci gut colonization.
ConclusionHigh prevalence of vancomycin resistant Enterococci gut colonization was found.
Previous exposure to antibiotics for more than two weeks and previous hospitalization for more than six months were significant factors for vancomycin resistant Enterococci colonization.
The isolated Enterococci had variable degrees of resistance to commonly prescribed antibiotics.
Therefore, periodic surveillance on antimicrobial resistance pattern, adhering to rational use of antibiotics and implementing infection prevention protocols may reduce colonization by VRE.
Related Results
Capítulo 6 – HIV-AIDS, como tratar, o que fazer e o que não fazer durante o tratamento?
Capítulo 6 – HIV-AIDS, como tratar, o que fazer e o que não fazer durante o tratamento?
A infecção pelo vírus do HIV pode ocorrer de diversas maneiras, tendo sua principal forma a via sexual por meio do sexo desprotegido. O vírus do HIV fica em um período de incubação...
Vancomycin resistant Enterococci and its associated factors among HIV infected patients on anti-retroviral therapy in Ethiopia
Vancomycin resistant Enterococci and its associated factors among HIV infected patients on anti-retroviral therapy in Ethiopia
BackgroundThe emergence of vancomycin resistant Enterococci (VRE) has alarmed the global community due to its tendency for colonization of the gastrointestinal tract. Human Immunod...
Laboratory-based Evaluation of Wondfo HIV1/2 Rapid Test Kits in the Gambia, December 2020
Laboratory-based Evaluation of Wondfo HIV1/2 Rapid Test Kits in the Gambia, December 2020
Background: HIV rapid diagnosis in The Gambia is mainly done using Determine HIV-1/2 and First Response HIV 1.2.0 or SD Bioline HIV-1/2 3.0 for screening and sero-typing of HIV res...
GLYCOPEPTIDE SUSCEPTIBILITY AMONG STAPHYLOCOCCI AND ENTEROCOCCI ISOLATES FROM SULAIMANI HEALTH LABORATORIES
GLYCOPEPTIDE SUSCEPTIBILITY AMONG STAPHYLOCOCCI AND ENTEROCOCCI ISOLATES FROM SULAIMANI HEALTH LABORATORIES
Background
Glycopeptide antibiotics are bactericidal agents that inhibit late stage bacterial cell wall peptidoglycan synthesis in Gram-positive bacteria. They are used for multir...
In vitro antibacterial activity of LY333328, a new semisynthetic glycopeptide
In vitro antibacterial activity of LY333328, a new semisynthetic glycopeptide
LY333328 is a semisynthetic N-alkyl derivative of LY264826, a naturally occurring structural analog of vancomycin. LY333328 was evaluated for its in vitro inhibitory and bactericid...
Impact of HIV/AIDS scale-up on non-HIV priority services in Nyanza Province, Kenya
Impact of HIV/AIDS scale-up on non-HIV priority services in Nyanza Province, Kenya
Background: The HIV pandemic has attracted unprecedented scale-up in resources to curb its escalation and manage those afflicted. Although evidence from developing countries sugges...
The Impact of IL28B Gene Polymorphisms on Drug Responses
The Impact of IL28B Gene Polymorphisms on Drug Responses
To achieve high therapeutic efficacy in the patient, information on pharmacokinetics, pharmacodynamics, and pharmacogenetics is required. With the development of science and techno...
A novel high throughput microwell outgrowth assay for HIV infected cells
A novel high throughput microwell outgrowth assay for HIV infected cells
AbstractAlthough antiretroviral therapy (ART) is highly effective at suppressing HIV replication, a viral reservoir persists that can reseed infection if ART is interrupted. Curing...

